Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

NCT07192900 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Malignant Pleural Effusion
Malignant Mesothelioma
Pleural Effusion, Malignant
Metastasis to Pleura

Interventions

BIOLOGICAL: locally manufactured adoptive cellular therapy (ACT) product
DRUG: Interleukin-2

Sponsor

David Bartlett, MD

Collaborators

[object Object]
[object Object]
[object Object]